drugset / Trial / NCT04139330

NPC-06 to Acute Pain in Herpes Zoster

NCT04139330

Phase 2 Terminated 16 enrolled Nobelpharma
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this trial is to investigate the efficiency of pain relief and the safety of NPC-06 for the acute pain in herpes zoster in the placebo-controlled double-blind parallel group trial, in addition to explore the effective concentration of NPC-06.

Timeline

Start
2019-11-21
Primary completion
2021-02-28
Completion
2021-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Fosphenytoin Small molecule 12 mg/kg Intravenous
Subject Fosphenytoin Small molecule 18 mg/kg Intravenous

Indications